home / stock / igx:cc / igx:cc quote
Last: | $0.295 |
---|---|
Change Percent: | -4.84% |
Open: | $0.31 |
Close: | $0.31 |
High: | $0.31 |
Low: | $0.29 |
Volume: | 27,155 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.295 | $0.31 | $0.31 | $0.31 | $0.29 | 27,155 | 08-02-2022 |
$0.335 | $0.375 | $0.335 | $0.375 | $0.335 | 7,900 | 05-06-2022 |
$0.33 | $0.395 | $0.33 | $0.4 | $0.33 | 36,099 | 05-05-2022 |
$0.34 | $0.355 | $0.34 | $0.435 | $0.34 | 26,355 | 05-04-2022 |
$0.37 | $0.33 | $0.37 | $0.44 | $0.33 | 99,192 | 05-03-2022 |
$0.33 | $0.38 | $0.33 | $0.38 | $0.33 | 28,173 | 05-02-2022 |
$0.375 | $0.34 | $0.375 | $0.375 | $0.33 | 46,918 | 04-29-2022 |
$0.37 | $0.355 | $0.37 | $0.37 | $0.355 | 3,565 | 04-28-2022 |
$0.33 | $0.33 | $0.33 | $0.355 | $0.33 | 26,297 | 04-27-2022 |
$0.33 | $0.33 | $0.33 | $0.33 | $0.33 | 1,195 | 04-26-2022 |
$0.345 | $0.345 | $0.345 | $0.345 | $0.345 | 7,946 | 04-25-2022 |
$0.335 | $0.29 | $0.335 | $0.34 | $0.29 | 14,009 | 04-22-2022 |
$0.35 | $0.305 | $0.35 | $0.35 | $0.305 | 44,589 | 04-21-2022 |
$0.34 | $0.33 | $0.34 | $0.34 | $0.31 | 21,273 | 04-20-2022 |
$0.33 | $0.31 | $0.33 | $0.33 | $0.29 | 57,049 | 04-19-2022 |
$0.32 | $0.32 | $0.32 | $0.32 | $0.31 | 26,767 | 04-18-2022 |
$0.3 | $0.31 | $0.3 | $0.31 | $0.3 | 38,990 | 04-13-2022 |
$0.31 | $0.345 | $0.31 | $0.345 | $0.3 | 58,818 | 04-12-2022 |
$0.33 | $0.33 | $0.33 | $0.33 | $0.31 | 33,978 | 04-11-2022 |
$0.33 | $0.335 | $0.33 | $0.335 | $0.31 | 110,322 | 04-08-2022 |
News, Short Squeeze, Breakout and More Instantly...
Intelgenx Technologies Corp. Company Name:
IGX:CC Stock Symbol:
TSXC Market:
Intelgenx Technologies Corp. Website:
MONTREAL, July 03, 2024 (GLOBE NEWSWIRE) -- IntelGenx Corp. (the “Company” or “IntelGenx” a subsidiary of IntelGenx Technologies Corp.) (OTCQB: IGXT; TSX: IGX), has successfully completed the BUENA Alzheimer’s disease (AD) study. The BUENA study was designed as ...
MONTREAL, June 11, 2024 (GLOBE NEWSWIRE) -- IntelGenx Corp. (the “ Company ” or “ IntelGenx ” a subsidiary of IntelGenx Technologies Corp.) (OTCQB: IGXT; TSX: IGX), was granted protection pursuant to an order (as amended or amended and restated from time t...
MONTREAL, May 28, 2024 (GLOBE NEWSWIRE) -- As previously announced on May 17, 2024, IntelGenx Technologies Corp. (the “ Company ” or “ IntelGenx ”) (OCTQB: IGXT; TSX: IGX), a leading drug delivery company focused on the development and manufacturing o...